13th Annual Fall Midwest Thoracic and GI Oncology Conference


 

Targeting EGFR in NSCLC: Osimertinib, What is the Best TKI Upfront and Combination of EGFR +IO

554 views
December 19, 2018
Comments 0
Login to view comments. Click here to Login